This article needs to be updated. The reason given is: Results of the investigation and further implications in 2021 and into 2022..(May 2022) |
Native name | Caso Covaxin |
---|---|
Date | June 16, 2021 |
Time | (UTC−3) |
Duration | 3 years, 4 months and 14 days |
Location | Brazil |
Also known as | Covaxgate |
Type | Alleged overbilling of 20 million doses of Covaxin vaccine by members of the Brazilian government |
The Case Covaxin,[1] also known as Covaxgate,[2] refers to an investigation made by the Brazilian Federal Public Ministry (MPF), held on June 16, 2021,[3] which found evidence of irregularities in the purchase of 20 million doses by the Ministry of Health of the Indian vaccine Covaxin, with the value of the vaccines 1000% higher than initially foreseen.[4]
The Prosecutor General of the Republic has also asked to investigate whether President Jair Bolsonaro committed the crime of misfeasance, for allegedly failing to report to investigative bodies evidence of corruption in the negotiations to purchase the vaccine.[5]